Carrie Grady
Family Medicine · Logan, IANPI 1548484165
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$379
- Novo Nordisk$241
- AbbVie$205
- Amgen$180
- Mylan Specialty L.p.$156
- Sumitomo Pharma America, Inc.$136
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,58396%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,682 in reported general payments places this provider in the 90th percentile of 1,357 family medicine providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 194 | $225,180 |
| JardianceEmpagliflozin | 98 | $75,510 |
| EliquisApixaban | 91 | $52,544 |
| KerendiaFinerenone | 49 | $34,274 |
| FarxigaDapagliflozin Propanediol | 43 | $32,298 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $29,789 |
| MyrbetriqMirabegron | 60 | $29,289 |
| GemtesaVibegron | 46 | $26,975 |
| RexultiBrexpiprazole | 13 | $23,082 |
| Tresiba Flextouch U-200Insulin Degludec | 30 | $21,710 |
| OzempicSemaglutide | 22 | $20,362 |
| XareltoRivaroxaban | 26 | $20,212 |
| RybelsusSemaglutide | 13 | $13,182 |
| LinzessLinaclotide | 21 | $11,877 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $9,341 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $379 | $234,040205 claims |
| Boehringer IngelheimJardiance | $56 | $75,51098 claims |
| PfizerEliquis, Prempro | $132 | $57,790112 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $16 | $35,24947 claims |
| BayerKerendia | $41 | $34,27449 claims |
| Novo NordiskOzempic, Rybelsus | $241 | $33,54435 claims |
| AstraZenecaFarxiga | $128 | $32,29843 claims |
| Astellas Pharma US IncMyrbetriq | $19 | $29,28960 claims |
| Johnson & JohnsonXarelto, Invokana | $48 | $27,11038 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $136 | $26,97546 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $14 | $23,08213 claims |
| AbbVieLinzess, Savella | $205 | $17,37134 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Logan
- Kirk PetersonHuxley$576K
- Nicholas GoetschWaterloo$525K
- Stephen HarrisonClinton$249K
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
- Leslie George PaulsenMuscatine$136K
- Dylan LoweDes Moines$105K
- Michael AbouassalyWest Burlington$88K
- Kevin DeregnierWinterset$68K
- Laura MoellerAmes$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.